Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.45 |
| ▸ | HMGCR | P04035 | 3/20 | 0.45 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SELP | P16109 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31664700 | 1.00 | ALDH1A1 (0.52) | ALDH1A1LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL18614852 | 1.00 | ALDH1A1 (0.52) | ALDH1A1LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL8027862 | 0.90 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL9155902 | 0.90 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL8907002 | 0.90 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL2802419 | 0.90 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL11129684 | 0.90 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL21411191 | 0.90 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL20991348 | 0.90 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2AHSD17B10 | |
| SCHEMBL7121183 | 0.90 | ALDH1A1 (0.68) | ALDH1A1LMNAMEN1KMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114671851-B | Naphthalimide-tetrazine compound and preparation method and application thereof | 中国医学科学院药物研究所 | 2024-03-26 | — | — | CN | claimed |
| CN-116925118-A | Mcl-1 protein labeled probe based on click chemistry, preparation method and application | 山东师范大学 | 2023-10-24 | — | — | CN | claimed |
| CN-109475642-B | Lysine conjugated immunoglobulins | 卫材R&D管理有限公司 | 2023-05-02 | — | — | CN | claimed |
| US-20260116914-A1 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | NAUTILUS SUBSIDIARY INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20250349136-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | NAUTILUS SUBSIDIARY INC (US) | 2025-11-13 | — | — | US | disclosed |
| US-12394223-B2 | Methods and systems for computational decoding of biological, chemical, and physical entities | NAUTILUS SUBSIDIARY, INC. (US) | 2025-08-19 | — | — | US | disclosed |
| US-12306093-B2 | Methods and systems for integrated on-chip single-molecule detection | NAUTILUS SUBSIDIARY, INC. (US) | 2025-05-20 | — | — | US | disclosed |
| US-20240249539-A1 | METHODS AND SYSTEMS FOR COMPUTATIONAL DECODING OF BIOLOGICAL, CHEMICAL, AND PHYSICAL ENTITIES | NAUTILUS SUBSIDIARY, INC. | 2024-07-25 | — | — | US | disclosed |
| CN-118340907-A | Polymer conjugates comprising bioactive agents | 波利艾克蒂瓦有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-118215676-A | Specific conjugation of antibody drug conjugates | 杭州多禧生物科技有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-114671851-B | Naphthalimide-tetrazine compound and preparation method and application thereof | 中国医学科学院药物研究所 | 2024-03-26 | — | — | CN | disclosed |
| CN-107670049-B | Full-degradable high-molecular antitumor drug with multi-drug synergistic effect and preparation method thereof | 湘潭大学 | 2020-04-07 | — | — | CN | disclosed |
| CN-110785428-A | Methods and reagents for analyzing protein-protein interfaces | 锐新医药公司 | 2020-02-11 | — | — | CN | disclosed |
| CN-107108822-B | Polymer and DNA copolymer coating | 伊鲁米纳剑桥有限公司 | 2020-02-07 | — | — | CN | disclosed |
| CN-110714005-A | Functional microsphere for enriching oxidized nucleic acid and method for enriching oxidized nucleic acid | 青岛大学 | 2020-01-21 | — | — | CN | disclosed |
| CN-110564811-A | Method for enriching oxidized nucleic acids | 青岛大学 | 2019-12-13 | — | — | CN | disclosed |
| CN-105985944-B | A kind of new method of intracellular site specific covalent labeled RNA | 中国科学院生物物理研究所 | 2019-05-28 | — | — | CN | disclosed |
| CN-105985944-A | Novel method of intracellular site-specific covalent RNA labeling | 中国科学院生物物理研究所 | 2016-10-05 | — | — | CN | disclosed |
| US-4604386-A | CONTROL OF GRAMPOSITIVE BACTERIA | ELI LILLY AND COMPANY (US) | 1986-08-05 | — | — | US | disclosed |
| EP-0168222-A2 | 3-(Alkynylalkyloxy) Cephalosporins | ELI LILLY AND COMPANY (US) | 1986-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116914-A1 | METHODS OF GENERATING NANOARRAYS AND MICROARRAYS | SPPL2B, SNAP29, SPPL2A | ALDH1A1 4090/4885LMNA 1200/4885MEN1 3758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.